Internal Medicine, Medical Oncology · Winter Park, FL
NPI
1003128703
Since 2010
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
460 N Orlando Ave Ste 200
Winter Park, FL, 32789
Phone (407) 898-5452
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.2M
228,620 services
Medicare patients, 2024
802
Average age 75
Drug cost, 2024
$5.2M
2,152 prescriptions
Company payments, 2025
$959
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yaman Suleiman was code J9299 (injection, nivolumab, 1 mg), 25,620 times for 17 patients. In total Yaman Suleiman billed 228,620 services in 149 codes, and Medicare paid $4.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9299 Injection, nivolumab, 1 mg | Office | 25,620 | 17 | $24.55 | $629K |
| J1756 Injection, iron sucrose, 1 mg | Office | 21,000 | 30 | $0.17 | $3,675 |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 17,850 | 18 | $0.28 | $4,941 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 12,000 | 14 | $44.53 | $534K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 11,280 | 34 | $6.39 | $72K |
| J0897 Injection, denosumab, 1 mg | Office | 7,860 | 64 | $20.57 | $162K |
| J0185 Injection, aprepitant, 1 mg | Office | 6,630 | 14 | $1.33 | $8,834 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,438 | 57 | $0.09 | $220 |
| 85025 Blood Count | Office | 2,382 | 673 | $7.60 | $18K |
| 36415 Venipuncture Blood Collection | Office | 2,379 | 667 | $8.65 | $21K |
| 99214 Office E&M - Established | Office | 1,362 | 503 | $94.33 | $128K |
| 96372 Injection Administration | Office | 1,131 | 207 | $10.33 | $12K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,020 | 25 | $0.69 | $699 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 993 | 470 | $12.71 | $13K |
| J1750 Injection, iron dextran, 50 mg | Office | 676 | 30 | $13.86 | $9,368 |
By year: 2022 $4.4M for 305,038 services; 2023 $3.6M for 241,357 services; 2024 $4.2M for 228,620 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,382 | 673 | $7.60 | $18K |
| 36415 Venipuncture Blood Collection | 2,379 | 667 | $8.65 | $21K |
| 85046 Blood Count | 264 | 193 | $5.46 | $1,441 |
| 85610 Clinical Chemistry | 73 | 13 | $4.20 | $307 |
| 81003 Clinical Chemistry | 44 | 19 | $2.20 | $96.8 |
| 85045 Blood Count | 17 | 15 | $3.91 | $66.47 |
Medicare prescription drug claims, 2024
In 2024, the drug Yaman Suleiman prescribed most often to Medicare patients was Eliquis (Apixaban), with 202 prescriptions and refills. In total Yaman Suleiman wrote 2,152 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 202 | 298 | 49 | $172K |
| Prednisone Generic | 125 | 165 | 40 | $750 |
| Letrozole Generic | 111 | 306 | 38 | $2,626 |
| Tramadol Hcl Generic | 66 | 66 | 18 | $366 |
| Levothyroxine Sodium Generic | 57 | 144 | 22 | $390 |
| Revlimid Lenalidomide | 52 | 52 | Under 11 | $816K |
| Abiraterone Acetate Generic | 46 | 46 | Under 11 | $40K |
| Lorazepam Generic | 45 | 45 | 26 | $238 |
| Gabapentin Generic | 43 | 57 | 11 | $670 |
| Warfarin Sodium Generic | 42 | 111 | Under 11 | $292 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 41 | 120 | 22 | $539 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 41 | 41 | 12 | $960 |
| Oxycodone Hcl Generic | 39 | 40 | 19 | $470 |
| Hydroxyurea Generic | 38 | 72 | Under 11 | $864 |
| Acyclovir Generic | 37 | 45 | Under 11 | $680 |
Brand drugs: - claims; generic drugs: 1,510 claims; opioid claims: 243.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yaman Suleiman $959 ($959 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $144.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $144 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $119 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $114 |
| BeOne Medicines USA, Inc. ONC | 5 | $99.34 |
| Celgene Corporation BMY | 3 | $64.85 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $63.43 |
| Astellas Pharma US Inc 4503.T | 3 | $60.12 |
| Gilead Sciences, Inc. GILD | 2 | $38.71 |
| Legend Biotech USA Inc. LEGN | 1 | $34.36 |
| Lilly USA, LLC LLY | 1 | $33.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.